Brief: Lee's Pharma Updates On Possible Spin-Off And Listing of Zhaoke Ophthalmology
20/11/2020 15:16
Nov 20 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* GOT APPROVAL OF PN15 APPLICATION FROM STOCK EXCHANGE THAT
IT MAY
PROCEED WITH POSSIBLE SPIN-OFF AND LISTING
Source text for Eikon: ID:nHKSTxFW2
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA